ISTH 2020 Congress
Thrombotic Microangiopathies
Theme Navigation
- ISTH 2020 Congress
- Thrombotic Microangiopathies
Abstract Number: PB1882
Acquired Thrombotic Thrombocytopenic Purpura: Key Findings of Patients from Southern Italy
Abstract Number: OC 07.2
ADAMTS13 Conformation Is Closed in Acquired Thrombotic Thrombocytopenic Purpura in the Absence of Anti-ADAMTS13 Autoantibodies
Abstract Number: PB1947
An Unusual Case of Cerebral Cavernous Malformation Complicated with Consumptive Coagulopathy and Heightened Fibrinolysis
Abstract Number: PB1919
Anti-β2-Glycoprotein I and Anti-Prothrombin Antibodies Cause Lupus Anticoagulant by Interfering with Factor Xa-Mediated Factor V Activation
Abstract Number: PB1911
Antiphospholipid Antibodies “Multi-Positivity” in Women with Thromboembolism
Abstract Number: PB1904
Assessment and Comparison of Acquired Activated Protein C Resistance with Two Thrombin Generation Methods, CAT and ST-Genesia, in APS and SLE Patients
Abstract Number: PB1885
Association of Plasmic Score with Neurological Symptoms in Patients with Thrombotic Thrombocytopenic Purpura (TTP)
Abstract Number: PB1862
Automated Chemiluminescent ADAMTS13 Activity Immunoassay for Thrombotic Thrombocytopenic Purpura Diagnosis and Follow-up
Abstract Number: PB1863
Caplacizumab in a Case of Acquired Thrombotic Thrombcytopenic Purpura (TTP) Poor Responsive to Plasma Exchange and Immunosuppressive Therapy
Abstract Number: PB1923
Catastrophic Antiphospholipid Syndrome, Kikuchi-Fujimoto Disease and Adult-Onset Still Disease: An Unusual Association
Abstract Number: PB1932
CliA Immunoassay: Better Identification of High Thrombotic Risk Triple Positive Antiphospholipid Patients
Abstract Number: PB1867
Clinical Analysis of 83 Patients with Thrombotic Thrombocytopenic Purpura
Abstract Number: PB1889
Clinical and Economic Impacts of a New Rapid ADAMTS-13 Assay for the Diagnosis of Suspected Thrombotic Thrombocytopenic Purpura
Abstract Number: PB1909
Cohort of Patients with Triple Antiphospholipid Antibodies: Differences between Asymptomatic and Symptomatic Individuals
Abstract Number: PB1945
Complement Pathway and Endothelial Dysfunction in Severe Preeclampsia
Abstract Number: PB1925
Complement Regulatory Abnormalities are Frequent in Patients with Catastrophic APS and Refractory Patients Respond Rapidly to Eculizumab Treatment
Abstract Number: PB1933
Contribution of Beta2 Glycoprotein1 IgA (B2GP1 IgA) Antibodies Research in Diagnosis of Seronegative Antiphospholipid Syndrome in Cerebral Thrombosis: A Case Series of 21 Patients
Abstract Number: PB1884
Correlation between Phenotype-genotype versus in-silico Prediction of Novel and Known Disease-causing Variants in Upshaw-Schulman Syndrome Patients in a Single Institution of Argentina
Abstract Number: PB/CO21
COVID-19 Pandemic: Dissecting Coagulation apart from Inflammation
Abstract Number: PB1864
Current Possibilities of ADAMTS 13 Diagnostics – Advantages and Limitations